A new consensus report on the management of type 1 diabetes in adults was presented recently at the European Association for the Study of Diabetes (EASD) meetings. This is an EASD/American Diabetes ...
This week, the FDA approved a new treatment called teplizumab that delays the onset of type 1 diabetes. TZIELD, the brand name, will total $193,000 over the 14-day treatment. Experts say the new ...
Fulminant type 1 diabetes is a recently discovered subtype of type 1 diabetes. It is defined as diabetes in which the process of β-cell destruction and the progression of hyperglycemia and ...
Children who were recently diagnosed with type 1 diabetes need less supplemental insulin to keep their blood sugar in a healthy range if they use the immunotherapy drug teplizumab, a new study reports ...
This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. In 2024 Stephen Rich and his colleagues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback